ketanserin has been researched along with Trigeminal Neuralgia in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Trigeminal Neuralgia: A syndrome characterized by recurrent episodes of excruciating pain lasting several seconds or longer in the sensory distribution of the TRIGEMINAL NERVE. Pain may be initiated by stimulation of trigger points on the face, lips, or gums or by movement of facial muscles or chewing. Associated conditions include MULTIPLE SCLEROSIS, vascular anomalies, ANEURYSMS, and neoplasms. (Adams et al., Principles of Neurology, 6th ed, p187)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Yuan, S | 1 |
Wang, N | 1 |
Yao, Y | 1 |
Liu, J | 1 |
Gao, M | 1 |
Mo, H | 1 |
Zhang, S | 1 |
Su, R | 1 |
1 other study available for ketanserin and Trigeminal Neuralgia
Article | Year |
---|---|
Role of 5-HT
Topics: Animals; Ketanserin; Mice; Pain; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, | 2022 |